Cargando…
Licensing Natural Killers for Antiviral Immunity
Immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptors (IRs) enable discrimination between self- and non-self molecules on the surface of host target cells. In this regard, they have a vital role in self-tolerance through binding and activating intracellular tyrosine phosphatases wh...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308748/ https://www.ncbi.nlm.nih.gov/pubmed/34358058 http://dx.doi.org/10.3390/pathogens10070908 |
_version_ | 1783728355565109248 |
---|---|
author | Cronk, John M. Fafoutis, Eleni Brown, Michael G. |
author_facet | Cronk, John M. Fafoutis, Eleni Brown, Michael G. |
author_sort | Cronk, John M. |
collection | PubMed |
description | Immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptors (IRs) enable discrimination between self- and non-self molecules on the surface of host target cells. In this regard, they have a vital role in self-tolerance through binding and activating intracellular tyrosine phosphatases which can inhibit cellular activation. Yet, self-MHC class I (MHC I)-specific IRs are versatile in that they can also positively impact lymphocyte functionality, as exemplified by their role in natural killer (NK) cell education, often referred to as ’licensing‘. Recent discoveries using defined mouse models of cytomegalovirus (CMV) infection have revealed that select self-MHC I IRs can increase NK cell antiviral defenses as well, whereas other licensing IRs cannot, or instead impede virus-specific NK responses for reasons that remain poorly understood. This review highlights a role for self-MHC I ‘licensing’ IRs in antiviral immunity, especially in the context of CMV infection, their impact on virus-specific NK cells during acute infection, and their potential to affect viral pathogenesis and disease. |
format | Online Article Text |
id | pubmed-8308748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83087482021-07-25 Licensing Natural Killers for Antiviral Immunity Cronk, John M. Fafoutis, Eleni Brown, Michael G. Pathogens Review Immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptors (IRs) enable discrimination between self- and non-self molecules on the surface of host target cells. In this regard, they have a vital role in self-tolerance through binding and activating intracellular tyrosine phosphatases which can inhibit cellular activation. Yet, self-MHC class I (MHC I)-specific IRs are versatile in that they can also positively impact lymphocyte functionality, as exemplified by their role in natural killer (NK) cell education, often referred to as ’licensing‘. Recent discoveries using defined mouse models of cytomegalovirus (CMV) infection have revealed that select self-MHC I IRs can increase NK cell antiviral defenses as well, whereas other licensing IRs cannot, or instead impede virus-specific NK responses for reasons that remain poorly understood. This review highlights a role for self-MHC I ‘licensing’ IRs in antiviral immunity, especially in the context of CMV infection, their impact on virus-specific NK cells during acute infection, and their potential to affect viral pathogenesis and disease. MDPI 2021-07-19 /pmc/articles/PMC8308748/ /pubmed/34358058 http://dx.doi.org/10.3390/pathogens10070908 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cronk, John M. Fafoutis, Eleni Brown, Michael G. Licensing Natural Killers for Antiviral Immunity |
title | Licensing Natural Killers for Antiviral Immunity |
title_full | Licensing Natural Killers for Antiviral Immunity |
title_fullStr | Licensing Natural Killers for Antiviral Immunity |
title_full_unstemmed | Licensing Natural Killers for Antiviral Immunity |
title_short | Licensing Natural Killers for Antiviral Immunity |
title_sort | licensing natural killers for antiviral immunity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308748/ https://www.ncbi.nlm.nih.gov/pubmed/34358058 http://dx.doi.org/10.3390/pathogens10070908 |
work_keys_str_mv | AT cronkjohnm licensingnaturalkillersforantiviralimmunity AT fafoutiseleni licensingnaturalkillersforantiviralimmunity AT brownmichaelg licensingnaturalkillersforantiviralimmunity |